Serving to inspireServing to inspireServing to inspire
YASHK is a vibrant community of young scientists dedicated to serving the community by enlightening future S&T talents.
Serving to inspire
Serving to inspireServing to inspireServing to inspire
YASHK is a vibrant community of young scientists dedicated to serving the community by enlightening future S&T talents.
Highlights
Professor Xuechen LI has developed a new antibiotic called Kynomycin, which has obtained the Drug Clinical Trial Approval Notification from the National Medical Products Administration, allowing for clinical trials to be conducted.
